Chryseobacterium indologenes bacteraemia in a diabetic child

Journal of Medical Microbiology

Volumn 54, Issue 7, 2005, Pages 677-680

  Cascio, Antonio ^a   Stassi, Giovanna ^a   Costa, Gaetano B ^a   Crisafulli, Giuseppe ^a   Rulli, Immacolata ^a   Ruggeri, Caterina ^a   Iaria, Chiara ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; DEXAMETHASONE; INSULIN; MANNITOL; POTASSIUM CHLORIDE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; CASE REPORT; CHILD; CHRYSEOBACTERIUM INDOLOGENES; DIABETES MELLITUS; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CATHETERIZATION, PERIPHERAL; CEFTRIAXONE; CHILD, PRESCHOOL; CHRYSEOBACTERIUM; DIABETES MELLITUS, TYPE 1; FLAVOBACTERIACEAE INFECTIONS; HUMANS; MALE;

EID: 21244443841     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.46036-0     Document Type: Article

References (11)

1. Bloch, K. C., Nadarajah, R. & Jacobs, R. (1997). Chryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Report of 6 cases and literature review. Medicine (Baltimore) 76, 30-41.
2. Green, B. T. & Nolan, P. E. (2001). Cellulitis and bacteraemia due to Chryseobacterium indologenes. J Infect 42, 219-220.
3. Hoque, S. N., Graham, J., Kaufmann, M. E. & Tabaqchali, S. (2001). Chryseobacterium (Flavobacterium) meningosepticum outbreak associated with colonization of water taps in a neonatal intensive care unit. J Hosp Infect 47, 188-192.
4. Hsueh, P. R., Teng, L J., Ho, S. W., Hsieh, W. C. & Luh, K. T. (1996a). Clinical and microbiological characteristics of Flavobacterium indologenes infections associated with indwelling devices. J Clin Microbiol 34, 1908-1913.
5. Hsueh, P. R., Hsiue, T. R., Wu, J. J., Teng, L. J., Ho, S. W., Hsieh, W. C. & Luh, K. T. (1996b). Flavobacterium indologenes bacteremia: clinical and microbiological characteristics. Clin Infect Dis 23, 550-555.
6. Hsueh, P. R., Teng, L. J., Yang, P. C., Ho, S. W., Hsieh, W. C. & Luh, K. T. (1997a). Increasing incidence of nosocomial Chryseobacterium indologenes infections in Taiwan. Eur J Clin Microbiol Infect Dis 16, 568-574.
7. Hsueh, P. R., Teng, L. J., Yang, P. C., Ho, S. W. & Luh, K. T. (1997b). Susceptibilities of Chryseobacterium indologenes and Chryseobacterium meningosepticum to cefepime and cefpirome. J Clin Microbiol 35, 3323-3324.
8. Kirby, J. T., Sader, H. S., Walsh, T. R. & Jones, R. N. (2004). Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: report from the SENTRY Antimicrobial Surveillance Program (1997-2001). J Clin Microbiol 42, 445-448.
9. Lin, J. T., Wang, W. S., Yen, C. C., Liu, J. H., Chlou, T. J., Yang, M. H., Chao, T. C. & Chen, P. M. (2003). Chryseobacterium indologenes bacteremia in a bone marrow transplant recipient with chronic graft-versus-host disease. Scand J Infect Dis 35, 882-883.
10. Nulens, E., Bussels, B., Bols, A., Gordts, B. & Van Landuyt, H. W. (2001). Recurrent bacterernia by Chryseobacterium indologenes in an oncology patient with a totally implanted intravascular device. Clin Microbiol Infect 7, 391-393.
11. Schreckenberger, P. C. & von Graevenitz, A. (1999). Acinetobacter, Alcaligenes, Moraxella, and other nonfermentative gram-negative rods. In Manual of Clinical Microbiology, pp. 539-560. Edited by P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover & R. H. Yolken. Washington, DC: American Society for Microbiology.